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OBJECTIVES: The main purpose of this study was to evaluate changes in the time trends of stomach, colorec-
tal, and esophageal cancer during the past decade in Iran. 
METHODS: Cancer incidence data for the years 2001 to 2010 were obtained from the cancer registration of 
the Ministry of Health. All incidence rates were directly age-standardized to the world standard population. In 
order to identified significant changes in time trends, we performed a joinpoint analysis. The annual percent 
change (APC) for each segment of the trends was then calculated.
RESULTS: The incidence of stomach cancer increased from 4.18 and 2.41 per 100,000 population in men and 
women, respectively, in 2001 to 17.06 (APC, 16.7%) and 8.85 (APC, 16.2%) per 100,000 population in 2010 
for men and women, respectively. The corresponding values for colorectal cancer were 2.12 and 2.00 per 100,000 
population for men and women, respectively, in 2001 and 11.28 (APC, 20.0%) and 10.33 (APC, 20.0%) per 
100,000 in 2010. For esophageal cancer, the corresponding increase was from 3.25 and 2.10 per 100,000 pop-
ulation in 2001 to 5.57 (APC, 12.0%) and 5.62 (APC, 11.2%) per 100,000 population among men and wom-
en, respectively. The incidence increased most rapidly for stomach cancer in men and women aged 80 years 
and older (APC, 23.7% for men; APC, 18.6% for women), for colorectal cancer in men aged 60 to 69 years 
(APC, 24.2%) and in women aged 50 to 59 years (APC, 25.1%), and for esophageal cancer in men and women 
aged 80 years and older (APC, 17.5% for men; APC,15.3% for women) over the period of the study. 
CONCLUSIONS: The incidence of gastrointestinal cancer significantly increased during the past decade. There-
fore, monitoring the trends of cancer incidence can assist efforts for cancer prevention and control. 
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INTRODUCTION
Cancer is an important public health challenge in Iran, as well 
as in most countries worldwide [1]. In Iran, after cardiovascular 
diseases and accidents, cancer is the third most common cause 
of death. Although the rate of cancer incidence in developed 
countries is generally two times greater than that in developing 
countries, the number of people affected by cancer yearly in 
developing countries is higher, and their disease is also more 
deadly [2]. Cancer in Iran shows considerably different patterns 
than those that exist in developed countries. For example, stom-
ach and esophageal cancers, which are the most prevalent types 
of cancer in Iran, are much less common in some other coun-
tries, especially the US, where they are not among the top 10 
prevalent types of cancer [3]. In this study, we used cancer reg-
istration data. Cancer registration is a tool for measuring cancer 
incidence in a defined population during a specific period of 
time in order to evaluate and control for the effects of cancer in 
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society [4]. The obtained data can be used for studying trends 
in cancer incidence, trends, patient follow-up, and survival [5]. 
Moreover, cancer registration is an important part of cancer 
control programs, and registration data can be used widely in 
etiologic research, evaluation of the effects of preventive mea-
sures, and program development in healthcare services [6]. Stom-
ach, colorectal, and esophageal cancers have a high incidence 
among Iranian men and women; colorectal and stomach can-
cers are among the five most prevalent cancers, and esophageal 
cancer is among the 10 most prevalent cancers.
Iran is experiencing changes in age demographics, economic 
development, and social transformations, which can have sig-
nificant effects on cancer patterns and changes in cancer trends. 
The main purpose of the current study was to evaluate the time 
trends of age-standardized incidence rates (ASRs) and identify 
changes in the incidence of gastrointestinal cancers (stomach, 
colorectal, and esophageal) from 2001 to 2010.
MATERIALS AND METHODS
The cancer incidence statistics for 2001 to 2010 were obtained 
from the National Cancer Control Program in Iran (Ministry of 
Health). The Iran cancer registry program is designed to register 
all cancer cases in the country. All pathology centers and other 
information sources such as hospitals’ medical records, mortali-
ty data from provincial governments, hematology-oncology cen-
ters, radiotherapy centers, and so on are obliged to report their 
data to the Cancer Office of Disease Control and Prevention 
(CDC). The CDC then annually enters the data in a computer 
program, identifies duplicates and reconciling the new data with 
the data from previous years. The executive arms of the program 
include all medical universities in the country. The three cancer 
sites included in this study were defined according to the Inter-
national Classification of Diseases, 10th revision. Stomach can-
cer was defined by code C16, esophageal cancer by code C15, 
and colorectal cancer by codes C18 to C21. We used ASRs in 
order to compare populations with different age structures, with 
weights obtained from the world standard population [7]. We 
then compared the incidence rates for five specific age groups 
(40-49 years, 50-59 years, 60-69 years, 70-79 years, and 80 
years and older).
For analysis, we used joinpoint regression analysis to identify 
the years when significant changes took place in the ASRs. Join-
point regression analysis fits a series of joined straight lines to 
the ASRs on a log scale [8]. Straight line segments are joined at 
joinpoints, where the incidence trend changes its slope to a sta-
tistically significant extent. We allowed a maximum of two join-
points, and an overall significance level of 5% was used for the 
comparisons of models applied to each data series. The best-fit-
ting model was estimated separately for men and women. The 
Joinpoint version 4.2.0.2 (https://surveillance.cancer.gov/join-
point/) was used for the statistical analysis.
RESULTS
Stomach cancer
For stomach cancer, a significant increase in incidence was ob-
served for both men and women, with annual percent changes 
(APCs) of 16.7% (95% confidence interval [CI], 14.6 to 18.8%) 
and 16.2% (95% CI, 7.7 to 25.4%), respectively, from 2001 to 
2010. The ASR for men was higher than for women (Table 1). 
In men, the incidence significantly increased from 2001 to 2008; 
however, this trend changed in 2008, after which no significant 
increase was observed. However, in women, the incidence in-
creased throughout the study period (Figure 1). In men and 
women, the highest incidence changes were observed in the 
age group of 80 years old above and higher (APC, 23.7% for 
men; APC, 18.6% for women) (Table 2). The ASRs of stomach 
cancer by birth cohort is plotted in Figure 2. The incidence incre-
ased as the birth cohort advanced, with more substantial increa-
ses in later birth cohorts for both men and women.
Colorectal cancer
For colorectal cancer, a significant increase was found in both 
Table 1. CRs and ASRs for gastrointestinal cancers in men and women in Iran, 2001-2010
Cancer site
Men Women
2001 2010 2001 2010
No. of 
cases CR ASR
No. of 
cases CR ASR APC 
No. of 
cases CR ASR
No. of 
cases CR ASR APC
Stomach 1,105 3.3 4.18 5,192 13.2 17.06 16.7* 484 1.5 2.41 2,238 6.5 8.85 16.2*
Colorectal 379 1.3 2.12 3,443 8.8 11.28 20.0* 344 1.2 2.00 2,641 7.7 10.33 20.0*
Esophageal 858 2.5 3.25 1,693 4.3 5.57 12.0* 405 1.3 2.10 1,378 4.0 5.62 11.2*
CR, crude rates (per 100,000); ASR, age-standardized incidence rates (per 100,000); APC, annual percent change of ASRs.
*p<0.05.
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from 2008 to 2010 (Figure 1). In both men and women, the 
highest increase in the APC was observed individuals 80 years 
of age or older (APC, 17.5% in men; APC, 15.3% in women) 
(Table 2). The ASIRs of eso phageal cancer by birth cohort are 
plotted in Figure 2. The incidence increased in later birth co-
horts in both men and women.
DISCUSSION
This study documented the incidence of gastrointestinal can-
cers in Iran during a 10-year period. The cancers studied showed 
an increasing trend during the study period. Two reasons for this 
increase can be proposed: first, changes in lifestyle and food pat-
terns to become more similar to those of Western countries, and 
second, improvements in the diagnosis and registration of can-
cer cases.
Evidence indicates that Helicobacter pylori is a cause of stom-
ach cancer, and the decreasing trend of stomach cancer in de-
Figure 1. Trends in the age-standardized incidence rate (ASR) for 
gastrointestinal cancers (A: stomach, B: colorectal, and C: esopha-
geal) in Iran, 2001-2010. 
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men and women during the study period, but the trend did not 
differ between men and women (APC, 20% for both men and 
women) (Table 1). The incidence trend for both groups signifi-
cantly increased from 2001 to 2008, and then became approxi-
mately stable. The decrease in men was greater than the decrease 
in women (Figure 1). In men, the highest APC was found in the 
age group of 60 to 69 years, and in women, the highest APC 
was found in the age group of 50 to 59 years (APC, 24.2% for 
men; APC, 25.1% for women) (Table 2). The ASRs of colorectal 
cancer by birth cohort are plotted in Figure 2. The incidence in-
creased in later birth cohorts for both men and women.
Esophageal cancer
A significant increase in the incidence of esophageal cancer 
in men and women was observed from 2001 to 2010 (APC, 
12% for men; APC, 11.2% for women) (Table 1). No differ-
ence in the trend of the incidence rate of esophageal cancer 
was found between men and women. A significantly increas-
ing trend was found from 2001 to 2008, while it decreased 
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Table 2. Trends in the ASRs for gastrointestinal cancers in Iranian men and women according to a joinpoint analysis by age group (2001-
2010)
Cancer site, age APC (95% CI) 2001-2010 Trend 1 APC (95% CI) Trend 2 APC (95% CI) Trend 3 APC (95% CI)
Men
Stomach
   40-49 12.4 (0.6, 25.7) 2001-2003 54.2 (-21.8, 204.0) 2003-2008 11.9 (-9.7, 38.7) 2008-2010 -17 (-57.9, 63.7)
   50-59 9.8 (6.3, 13.3) 2001-2003 41.4 (16.4, 71.7) 2003-2008 10.2 (3.6, 17.2) 2008-2010 -15.6 (-30.5, 2.5)
   60-69 12.3 (6.5, 18.4)* 2001-2003 41.5 (6.5, 88.0)* 2003-2010 5.1 (1.2, 9.2) N/A N/A 
   70-79  16.6 (12.4, 21.0) 2001-2003 63.4 (30.6, 104.4) 2003-2008 9.6 (2.1, 17.6) 2008-2010 -2.9 (-22.3, 21.5)
   80+ 23.7 (14.3, 33.9) 2001-2004 63.6 (26.3, 112.0) 2004-2010 7.6 (-1.5, 17.4) N/A N/A 
   All 16.7 (14.6, 18.8)* 2001-2003 70.4 (52.6, 90.3)* 2003-2008 8.9 (5.1, 12.8)* 2008-2010 -5.1 (-15.0, 6.0)
Colorectal 
   40-49 13.0 (10.4, 15.6)* 2001-2003 46.7 (27.6, 68.6)* 2003-2008 15.1 (10.1, 20.3)* 2008-2010 -16.9 (-27.7,  -4.5)*
   50-59 17.2 (11.8, 22.8)* 2001-2003 52.9 (15.0, 103.3)* 2003-2008 17.6 (7.5, 28.7)* 2008-2010 -11.0 (-33.1, 18.3)
   60-69 24.2 (16.1, 32.9)* 2001-2003 62.3 (13.1, 133.1)* 2003-2010 15.1 (9.7, 20.8)* N/A N/A 
   70-79 21.0 (15.4, 26.9)* 2001-2004 43.1 (22.7, 66.9)* 2004-2010 11.3 (5.6, 17.2)* N/A N/A 
   80+ 21.2 (11.9, 31.3)* 2001-2007 35.9 (24.4.8, 48.4)* 2007-2010 -3.6 (-25.7, 25.2) N/A N/A 
   All 20.0 (15.6, 24.6)* 2001-2003 63.3 (30.0, 105.1)* 2003-2008 15.9 (7.8, 24.5)* 2008-2010 -3.8 (-23.4, -0.7)
Esophageal 
   40-49 9.2 (-6.0, 26.8) 2001-2004 42.8 (-10.0, 126.5) 2004-2008 6.2 (-33.1, 38.4) 2008-2010 -22.9(-69.4, 94.1)
   50-59 12.5 (6.5, 18.8)* 2001-2003 64.3 (17.6, 129.6)* 2003-2008 10.8 (-0.3, 23.2) 2008-2010 -20 (-42.7.2, 11.7)
   60-69 14.3 (6.2, 23.1)* 2001-2003 57.7 (6.4, 133.7)* 2003-2010 4.3 (-1.0, 9.9) N/A N/A 
   70-79 13.4 (5.2, 22.2)* 2001-2005 31.7 (11.6, 55.5)* 2005-2010 0.6 (-10.6, 13.1) N/A N/A 
   80+ 17.5 (6.4, 29.8)* 2001-2003 77.1 (-3.3, 224.4) 2003-2008 15.5 (-4.6, 39.9) 2008-2010 -18.6 (-55.6, 49.0)
   All 12.0 (6.6, 17.7)* 2001-2003 54.6 (14.1, 109.4)* 2003-2008 8.9 (-1.1, 19.9) 2008-2010 -12.8 (-35.7, 18.1) 
Women 
Stomach
   40-49 12.1 (3.4, 21.6) 2001-2004 38.3 (13.0, 69.3) 2004-2008 12.3 (-6.3, 34.6) 2008-2010 -18.5 (-57.3, 55.3)
   50-59 14.6 (8.5, 21.0) 2001-2004 35.8 (13.8, 62.1) 2004-2010 5.3 (-0.9, 11.7) N/A N/A
   60-69 13.1 (5.9, 20.8)* 2001-2004 35.6 (9.5, 68.0)* 2004-2010 3.3 (-3.9, 11.0) N/A N/A
   70-79 16.1 (8.8, 23.9) 2001-2003 40.1 (-1.2, 98.7) 2003-2010 10.0 (5.0, 15.3) N/A N/A
   80+ 18.6 (13.9, 23.5) N/A N/A N/A N/A N/A N/A 
   All 16.2 (7.7, 25.4)* 2001-2003 53.3 (2.1, 130.1)* 2003-2010 7.4 (1.7, 13.4)* N/A N/A 
Colorectal
   40-49 18.6 (8.3, 29.8)* N/A N/A N/A N/A N/A N/A 
   50-59 25.1 (13.3, 38.2)* 2001-2003 69.3 (-0.3, 187.5) 2003-2010 14.8 (6.9, 23.2)* N/A N/A 
   60-69 19.5 (13.3, 26.1)* 2001-2004 52.8 (28.5, 81.8)* 2004-2010 5.7 (-0.3, 12.1) N/A N/A 
   70-79 20.2 (15.5, 25.1)* 2001-2004 48.3 (30.1, 69.1)* 2004-2010 8.2 (3.6, 13.1)*  N/A N/A 
   80+ 23.0 (10.9, 36.6)* 2001-2004 60.4 (14.2, 125.3)* 2004-2010 7.8 (-3.9, 20.9) - -
   All 20.0 (18.8, 21.3)* 2001-2003 66.8 (56.4, 78.0)* 2003-2008 13.8 (11.5, 16.1)* 2008-2010 -1.3 (-7.5, 5.3)
Esophageal
   40-49 6.5 (-1.8, 15.4) 2001-2003 62.7 (-0.4, 165.9) 2003-2008 1.9 (-1.7, 19.0) 2008-2010 -22.3 (-52.4, 27.0)
   50-59 14.0 (1.5, 28.2)* 2001-2003 52.8 (-18.2, 185.6) 2003-2010 4.9 (-3.5, 14.0) N/A N/A 
   60-69 13.9 (5.6, 22.9)* 2001-2003 70.8 (14.0, 155.8)* 2003-2010 1.5 (-3.9, 7.1) N/A N/A 
   70-79 12.6 (3.7, 22.4)* 2001-2003 52.3 (-8.1, 152.5) 2003-2008 9.7 (-6.5, 28.7) 2008-2010 -11.1 (-46.4, 47.4)
   80+ 15.3 (4.9, 26.8)* 2001-2003 28.7 (20.2, 37.7)* 2003-2010 -21.5(-52.7, 30.4) N/A N/A 
   All 11.2 (6.2, 16.5)* 2001-2003 54.5 (16.7, 104.7)* 2003-2008 7.4 (-1.7, 17.4) 2008-2010 -12.7 (-34.1, 15.6)
ASR, age-standardized incidence rate; APC, annual percentage change of ASRs; CI, confidence interval; N/A, not applicable.
*p<0.05.
veloped countries has been found to be significantly related to 
the decrease of infections with this bacterium. The International 
Agency for Research on Cancer has reported that H. pylori is 
the main reason for stomach cancer [9]. The prevalence of this 
bacterium in developing countries, such as Iran, is 80%, where-
as its prevalence in developed countries is 30% [10]. Therefore, 
the main reason for the increase in stomach cancer among Ira-
nians is likely to be infections with this bacterium. The 5% de-
crease in the incidence trend of this cancer in men from 2008 
to 2010 may have been related to the increase of antibiotic use 
to treat H. pylori infections. In most studies, it has been report-
ed that salt and salty foods can increase the incidence of this 
cancer, while the consumption of fruits, fresh vegetables, and 
fish can have a protective effect [11-13]. Although a healthy diet 
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Figure 2. Trends in the age-standardized incidence rate (ASR) of gastrointestinal cancers (A:stomach, B: colorectal, and C: esophageal) by 
age group.
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including fruits and vegetables prevails in Iran, in comparison 
with developed countries, in recent decades it has been observed 
that dietary trends are moving toward Western foods, such as 
conserved and fast foods [14]. 
Smoking is a risk factor for gastrointestinal cancers. In a co-
hort study, it was reported that the risk of stomach cancer in 
smokers was twice that in non-smokers, and in the majority of 
studies, a significant relationship between smoking and cancer 
was found [15-17]. In general, the trend in stomach cancer inci-
dence is decreasing simultaneously with the trend of smoking 
in developed countries, while these trends are concomitantly 
increasing in developing countries. Although we do not have 
exact information about smoking trends in the last decade in 
Iran, data about smoking in the 1990s in the country indicated 
that cigarette smoking prevalence decreased overall from 11.7 
to 14.6% among individuals 15 to 69 years of age [18]. It seems 
that smoking has not had a major effect on stomach cancer in-
cidence in Iran. Men gender is a risk factor for stomach cancer. 
In the current study, the incidence of stomach cancer in men 
was much higher than that in women. In some studies, this dif-
ference has been attributed to the protective role of woman hor-
mones [19].
Many studies have shown an increase in stomach cancer in 
Iran. Haidari et al. [20] found that the overall incidence rate of 
stomach cancer increased from 2.8 per 100,000 in 2000 to 9.1 
per 100,000 in 2005; moreover, Sadjadi et al. [21] in Ardabil 
province documented increase in the incidence of stomach can-
cer. Another study in Tehran and Shiraz indicated that the over-
all occurrence of stomach cancer slightly increased (0.08 for Teh-
ran, and 0.03 for Shiraz) [22]. While Iran is facing an increase in 
the incidence of stomach cancer, other research has suggested a 
decrease in stomach cancer incidence in some countries, such as 
Cyprus, Jordan, Egypt, South America, and European locations 
such as Spain and the state of Amberia in Italy. The decline in 
the incidence of stomach cancer in the US and Western Europe 
may have resulted from H. pylori infection control and the im-
pact of cancer control programs. 
According to GLOBOCAN 2012, colorectal cancer in Iran is 
the fourth most prevalent cancer among men and the second 
most prevalent among women [23]. In a systematic review in 
Iran, the ASRs of colorectal cancer were 8.16 per 100,000 and 
6.17 per 100,000 for men and women, respectively [24]. Najafi 
et al. [25] showed that the incidence of colorectal cancer in 1993 
to 2007 increased by 14%, which is consistent with our results. 
Additionally, in a report from Fars province, the ASR for colon 
cancer among men was 1.61 per 100,000 from 1970 to 1980 
and 4.20 per 100,000 from 1990 to 2000, with a significant an-
nual increase of 0.13 per 100,000 (p<0.05) [26]. Yazdizadeh et 
al. [22] concluded that the incidence of colon cancer increased 
in Fars and Tehran provinces during the past 30 years. The mag-
nitude of this increase, as measured by comparing the last five 
years to the first five years, was 82% for Tehran and 65% for 
Shiraz. 
In some European studies, colorectal cancer showed a trend 
of increasing incidence from 1984 to 2007 [27,28]. Moreover, 
in some Asian countries, such as China, Japan, South Korea, and 
Singapore, a 2-fold to 4-fold increase in colorectal cancer has 
been reported during the past decades [29]. Similarly, the cur-
rent study detected a considerable increase in cancer incidence 
among men and women during the study period.
Diet plays an important role in the development of colorectal 
cancer. Several cohort studies have revealed that consuming a 
considerable amount of fruits, vegetables, fish, and high-fiber 
foods can greatly decrease the incidence of this cancer [30,31]. 
One of the reasons for the increasing trend of colorectal cancer 
in Iran may be changes in dietary habits. Fast foods, which are 
typical of Western foods, are increasingly replacing Iranian tra-
ditional foods, which are mostly high in fiber [32]. Studies con-
ducted in Iran have indicated that fat consumption increased 
greatly from 1990 to 2000, and that this increase was accompa-
nied by an increase in the obesity rate [33,34]. Obesity, espe-
cially in the abdominal region, increases the risk of colorectal 
cancer by up to 40% in men and 16% in women [35]. Physical 
activity and maintaining an ideal weight can lead to a signifi-
cant decrease in the incidence of colorectal cancer, as physically 
active people are 20 to 30% less affected by this cancer [36]. 
Only 31% of the mature population of Iran engages in regular 
physical activity [14]. Consequently, obesity and inadequate 
physical activity are other reasons for the increased incidence 
of colorectal cancer among Iranians. Previous studies in North 
America indicated that the risk of cancer for 15 to 20% of the 
population can be attributed to smoking habits [36]. The smok-
ing prevalence in the mature population of Iran is approximate-
ly 14% [14]. In addition, colorectal cancer incidence increases 
with age. The risk of colorectal cancer increases slightly after 40 
years of age, but after 50, it increases rapidly [11,37]. Such a pat-
tern was observed in the current study; that is, the most posi-
tive trend of incidence was identified in men and women who 
were born in 1923 (age group of 80 to 84 years).
Iran is considered to be a country in the esophageal cancer 
belt, with a high incidence of this disease , and the highest inci-
dence rates have been reported from northern provinces such 
as Mazandaran, Golestan, and Khorasan [38]. According to stud-
ies, Gonbad-e Kavus in Golestan province, with an incidence 
rate of 100 per 100,000 individuals, has one of the greatest can-
cer incidence rates in Iran and the world. In contrast, Kerman 
province, with an incidence rate of three per 100,000 individu-
als, is considered to have a low risk by worldwide standards [39].
Esophageal cancer is related to smoking habits and alcohol 
consumption. These factors, as well as the low consumption of 
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fruits and vegetables, may account for 89% of the cases of this 
disease [40]. According to previous studies, the rate of esopha-
geal cancer incidence in northeastern regions of Golestan prov-
ince has decreased by half during the last 35 years. This consid-
erable decrease took place after great improvements in the eco-
nomic, social, and cultural status of the area [41]. The reasons 
for high rates of esophageal cancer incidence in Iran’s northeast 
have been analyzed in various studies during the past three de-
cades, especially the last 10 years. The main reasons have been 
identified as drinking hot tea, not consuming enough fruits and 
vegetables, using drugs and their derivatives, drinking unhealthy 
water, and poverty. Moreover, genetic factors among the popu-
lation of that area (Iran’s northeast) have been established as 
another reason for the high prevalence of this cancer [42-44]. 
Many studies in Iran have shown a reduced incidence of esoph-
ageal cancer. The majority of such studies were conducted be-
fore 2000. In contrast, our study identified an increased inci-
dence during the study period. Part of this inconsistency may 
be due to differences in survey techniques and the size of the 
population studied. During the 1970s, the diagnosis of esopha-
geal cancer was confirmed histologically in approximately 27% 
of cases [45], while in 2009 histological conformation was per-
formed in 86% of cases [46]. It is likely, therefore, that the re-
sults obtained at that point reflected an overestimation of the 
true diagnosis of esophageal cancer. Improved diagnostic facili-
ties, with greater accessibility of endoscopy for the diagnosis 
and the exact localization of upper gastrointestinal cancer, which 
plays a particularly important role in distinguishing cardia can-
cer from distal esophageal cancer, may be another reason for 
the decrease in esophageal cancer found in previous studies.
Part of the observed changes in the incidence of gastrointesti-
nal cancer may be related to improved diagnostic techniques 
and more efficient registration. Until 2004, the cancer registry 
was only based on pathology reports. Subsequently, the popu-
lation-based registration program in Iran expanded. According 
to a report of the Iranian Ministry of Health, the coverage of 
the cancer registry in Iran has increased from 18% in 1999 to 
81% in 2005 [46]. A study in Italy showed that a high propor-
tion of the increase in the incidence of stomach cancer was re-
lated to improvements in diagnostic techniques and the cancer 
registry system [47]. Additionally, previous studies in Iran have 
explicitly discussed the improvement in the cancer registry in 
Iran [48,49].
Gastrointestinal cancers showed a trend of increasing incidence 
in both genders from 2000 to 2010. The observed trends are as-
sociated with changes in lifestyle, socioeconomic conditions, and 
increased life expectancy. Therefore, it is essential to place a pri-
mary focus on prevention methods in order to reduce the inci-
dence of cancer.
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